Literature DB >> 29032748

Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.

Luqing Zhao1, Shengsheng Zhang1, Peijian He2.   

Abstract

The incidence and prevalence of inflammatory bowel diseases (IBD), which comprise ulcerative colitis and Crohn's disease, are increasing dramatically worldwide. Immunomodulators and biological agents can help but cause severe side effects in long-term use. As such, complementary and alternative medicine, in particular herbal remedy, is becoming more and more popular in the treatment of IBD patients. Many natural compounds have been used in clinical trials and some have been proven promising in IBD treatment. To achieve a better understanding of herbal therapy, researchers focus on understanding the underlying mechanisms by using experimental rodent models. The mechanism of the pathogenesis of IBD is complex involving both environmental and genetic factors. IBD is considered as a consequence of impaired epithelial barrier function, gut microbiota dysbiosis, and aberrant immune response. Studies have demonstrated that herbal medicine can improve epithelial proliferation and barrier integrity, restore microbiota homeostasis, and suppress hyper-immune reaction. This review is to summarize current understanding of the molecular basis of herbal treatment of IBD at the levels of epithelial, microbial, and immune regulation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Inflammatory bowel disease; epithelial barrier; herbal medicines; immune response; microbiota; pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 29032748     DOI: 10.2174/1381612823666171010124414

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

Review 1.  Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.

Authors:  Juan Decara; Patricia Rivera; Antonio Jesús López-Gambero; Antonia Serrano; Francisco Javier Pavón; Elena Baixeras; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

Review 2.  Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.

Authors:  Peng-De Lu; Yong-Hua Zhao
Journal:  Chin Med       Date:  2020-02-10       Impact factor: 5.455

3.  Quyu Shengxin Decoction Alleviates DSS-Induced Ulcerative Colitis in Mice by Suppressing RIP1/RIP3/NLRP3 Signalling.

Authors:  Chuang Wu; Haojie Yang; Changpeng Han; Qingming Wang; Haiyan Zhang; Ting Huang; Wenjing Mao; Cheng Tang; Wenjun Zhao; Zhiming Zhu; Jing Xu; Wei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-20       Impact factor: 2.629

4.  The effect of a fennel seed extract on the STAT signaling and intestinal barrier function.

Authors:  Barun Das; John Rabalais; Philip Kozan; Tina Lu; Nassim Durali; Kevin Okamoto; Matthew D McGeough; Beom Jae Lee; Kim E Barrett; Ronald Marchelletta; Mamata Sivagnanam
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

5.  Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis.

Authors:  You-Lan Chen; Ya-Li Zhang; Yan-Cheng Dai; Zhi-Peng Tang
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

6.  Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance.

Authors:  Jia Jia; Kai Zheng; Hong Shen; Jiangyi Yu; Ping Zhu; Shihai Yan; Yi Xu; Lei Zhu; Yuelin Lu; Peiqing Gu; Wan Feng
Journal:  BMC Complement Med Ther       Date:  2020-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.